AKGÜL ERDAL, M. Et Al. 2023. Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey. 46th European Cystic Fibrosis Conference , (viyana, Australia).

AKGÜL ERDAL, M., NAYIR BÜYÜKŞAHİN, H., ŞEN, V., kılıç sakallı, a. a., ÇOKUĞRAŞ, H. C., Demir, A. D., ... doğan, g.(2023). Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey . 46th European Cystic Fibrosis Conference, viyana, Australia

AKGÜL ERDAL, MELTEM Et Al. "Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey," 46th European Cystic Fibrosis Conference, viyana, Australia, 2023

AKGÜL ERDAL, MELTEM A. Et Al. "Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey." 46th European Cystic Fibrosis Conference , viyana, Australia, 2023

AKGÜL ERDAL, M. Et Al. (2023) . "Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey." 46th European Cystic Fibrosis Conference , viyana, Australia.

@conferencepaper{conferencepaper, author={MELTEM AKGÜL ERDAL Et Al. }, title={Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey}, congress name={46th European Cystic Fibrosis Conference}, city={viyana}, country={Australia}, year={2023}}